Asthma

Patients with refractory asthma exacerbations with respiratory failure treated with extracorporeal membrane oxygenation had decreased odds for death compared with standard care, according to study results published in CHEST.

SAN ANTONIO — Providers can use telemedicine to engage patients with asthma who face obstacles in access to care remotely, according to data presented at the American Academy of Allergy, Asthma & Immunology Annual Meeting.

Patients with asthma and other chronic illnesses in jail and prison in the United States may be undertreated compared with the general population, according to a study published in JAMA Health Forum.

The EPA has invited public comments on its proposal to update and strengthen its Mercury and Air Toxics Standards for coal-fired and oil-fired power plants, and the American Lung Association supports these potential changes.

Reduced mRNA levels of club cell secretory protein-16 — an anti-inflammatory protein — in bronchial epithelial cells are linked to asthma susceptibility, severity and exacerbations, according to study results.

Using oscillometry testing, physicians may identify patients with asthma and obesity who have a phenotype that may be related to worse symptoms and more severe disease, according to a study published in CHEST.

Incidence rates of asthma with recurrent exacerbations vary with time of surveillance, decade of birth, age, race, ethnicity and census region, according to a study published in The Journal of Allergy and Clinical Immunology.

A digital strategy for evidence-based asthma control led to modest improvements in medication adherence and significantly lower cost and treatment burdens, according to a study published in The Lancet Respiratory Medicine.

Patients with poor sleep patterns and higher genetic susceptibility have an additive higher risk for asthma, with lower risks among patients with healthy sleep patterns, according to a study published in BMJ Open Respiratory Research.

Fractional exhaled nitric oxide levels predicted treatment response to dupilumab among patients who had uncontrolled moderate to severe asthma, according to a study published in The Journal of Allergy and Clinical Immunology: In Practice.